WHO ICTRP trial

A prospective, single arm, open-label, interventional, pivotal study to evaluate…

DRKS00028739 · German Clinical Trials Register · Not Recruiting

Key facts

Trial ID DRKS00028739
Public title A prospective, single arm, open-label, interventional, pivotal study to evaluate the efficacy and safety of the Continuous Glucose Monitoring System ‘CareSens Air’ in adult patients with type 1 and type 2 diabetes
Scientific title A prospective, single arm, open-label, interventional, pivotal study to evaluate the efficacy and safety of the Continuous Glucose Monitoring System ‘CareSens Air’ in adult patients with type 1 and type 2 diabetes - IfDT-1936-IE
Primary sponsor i-SENS, Inc.
Registry German Clinical Trials Register
Recruitment status Not Recruiting
Study type interventional
Countries Germany
Conditions E14;Unspecified diabetes mellitus
Interventions Group 1: To compare the efficacy and safety of the devices subjects (persons with type 1 diabetes or type 2 diabetes) wear two systems for continuous glucose monitoring in parallel. The experimental phase (15x24 h, 16 calendar days)…
Registration date Jul 4, 2022
Target size 50
Secondary IDs CIV-21-11-038155
Registry page drks.de

At a glance

  • Yes Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations